Left Ventricular Systolic Dysfunction and Cardiovascular Outcomes in Tetralogy of Fallot: Systematic Review and Meta-analysis.

[1]  Stephanie Fuller,et al.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Circulation.

[2]  Hiren Patel,et al.  INFLUENCE OF RIGHT ATRIAL ENLARGEMENT ON READMISSION IN HEART FAILURE PATIENTS , 2019, Journal of the American College of Cardiology.

[3]  K. Gauvreau,et al.  Preoperative Predictors of Death and Sustained Ventricular Tachycardia After Pulmonary Valve Replacement in Patients With Repaired Tetralogy of Fallot Enrolled in the INDICATOR Cohort , 2018, Circulation.

[4]  A. Egbe,et al.  Progressive right ventricular enlargement due to pulmonary regurgitation: Clinical characteristics of a “low‐risk” group , 2018, American heart journal.

[5]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[6]  A. Zwinderman,et al.  Value of Cardiovascular Magnetic Resonance Imaging in Noninvasive Risk Stratification in Tetralogy of Fallot , 2017, JAMA cardiology.

[7]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[8]  J. Bauersachs,et al.  NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients with Tetralogy of Fallot and Pulmonary Regurgitation , 2016, The Thoracic and Cardiovascular Surgeon.

[9]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[10]  J. Bae.  A suggestion for quality assessment in systematic reviews of observational studies in nutritional epidemiology , 2016, Epidemiology and health.

[11]  B. Mulder,et al.  Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. , 2016, European heart journal.

[12]  M. Gutberlet,et al.  Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot , 2015, Heart.

[13]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[14]  M. Sá,et al.  Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. , 2013, Journal of the American College of Cardiology.

[15]  K. Gauvreau,et al.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort , 2013, Heart.

[16]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[17]  K. Dimopoulos,et al.  Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot , 2012, Circulation.

[18]  T. Geva.  Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[19]  Helmut Baumgartner,et al.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). , 2010, European heart journal.

[20]  Idith Haber,et al.  Effects of Regional Dysfunction and Late Gadolinium Enhancement on Global Right Ventricular Function and Exercise Capacity in Patients With Repaired Tetralogy of Fallot , 2009, Circulation.

[21]  A. Zwinderman,et al.  Preoperative Thresholds for Pulmonary Valve Replacement in Patients With Corrected Tetralogy of Fallot Using Cardiovascular Magnetic Resonance , 2007, Circulation.

[22]  E P Walsh,et al.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair , 2006, Heart.

[23]  D. Pennell,et al.  Ventricular Fibrosis Suggested by Cardiovascular Magnetic Resonance in Adults With Repaired Tetralogy of Fallot and Its Relationship to Adverse Markers of Clinical Outcome , 2006, Circulation.

[24]  Dudley J Pennell,et al.  Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. , 2002, Journal of the American College of Cardiology.

[25]  M. Miyagawa,et al.  Ischemic myocardial injury during cardiopulmonary bypass surgery. , 1973, American heart journal.